Dr. Máirín Ryan:

It is not ideal. It does not actually happen that often, particularly if there is a commercial sponsor behind a technology which has invested in producing the evidence. We have to be careful that the evidence is reflective of an Irish population, so for example evidence collected in a resource-limited setting might not be transferable to Ireland. Part of the work we do is assessing whether the population on which the technology is tested is sufficiently similar to the Irish population that we can be comfortable using that information.